OM3L:XETRA:XETRA-iShares MSCI USA ESG Enhanced UCITS ETF USD Inc (EUR)

ETF | Others |

Last Closing

USD 9.182

Change

+0.05 (+0.51)%

Market Cap

N/A

Volume

0.18M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-20 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.24 (+0.52%)

USD 96.80B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.36 (+0.36%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.09 (+0.38%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.06 (+0.47%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.02 (+0.33%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.09 (+0.39%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.07 (+0.56%)

USD 23.43B
PPFB:XETRA iShares Physical Gold ETC EUR

+0.18 (+0.33%)

USD 19.49B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.01 (+0.06%)

USD 12.83B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.12 (+0.10%)

USD 12.26B

ETFs Containing OM3L:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.47% 12% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.47% 14% F 15% F
Trailing 12 Months  
Capital Gain 6.58% 58% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.58% 60% D- 57% F
Trailing 5 Years  
Capital Gain 123.22% 80% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 123.22% 80% B- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 15.97% 84% B 81% B-
Dividend Return 16.16% 84% B 81% B-
Total Return 0.19% 21% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 16.38% 30% F 42% F
Risk Adjusted Return 98.65% 83% B 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.